Corticosteroid use for 2019-nCoV infection: A double-edged sword

Affiliations

¹ MBBS, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
² Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.

Comment

Sundus Nasim et al. Infect Control Hosp Epidemiol. 2020 Oct.

. 2020 Oct;41(10):1244-1245.

doi: 10.1017/ice.2020.165. Epub 2020 Apr 23.

¹ MBBS, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
² Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.

No abstract available

Comment on

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Russell CD, Millar JE, Baillie JK. Russell CD, et al. Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7. Lancet. 2020. PMID: 32043983 Free PMC article. No abstract available.

1. WHO director-general’s opening remarks at the media briefing on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re.... Published March 11, 2020. Accessed April 7, 2020.
1. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China J Med Microbiol 2003;52:715–720. - PubMed
1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069. - PMC - PubMed
1. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. doi: 10.1016/S2213-2600(20)30079-5. - DOI - PMC - PubMed
1. Wang Y, Jiang W, He Q, et al. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. medRxiv 2020. doi: 10.1101/2020.03.06.20032342. - DOI